Results 101 to 110 of about 699,373 (191)
Administering a subconjunctival injection. [PDF]
Practical article describing how to give a subconjunctival injection in order to administer medication in high ...
Sue Stevens, Stevens, Sue
core
Purpose: To investigate the effect of bevacizumab on corneal neovascularization in an alkali burn -induced model of corneal angiogenesis. Material and Method: Twenty-four Wistar albino rats were used in our study.
Feyza Dursun +11 more
core +1 more source
O objetivo deste estudo foi avaliar os efeitos da aplicação subconjuntival de bevacizumab (Avastin®) na angiogênese corneal em ratos. Vinte ratos Wistar, machos, foram submetidos a cauterização química com cristal de nitrato de prata.
Belfort-Junior, Rubens +1 more
core
Nandita Anand, James J Reidy, Kamran M RiazDepartment of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USAAbstract: We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster ...
Anand N, Reidy JJ, Riaz KM
doaj
Clinical study on effect of subconjunctival injection of bevacizumab on corneal neovascularization. [PDF]
The cornea has the unique feature of being normally avascular except for small loops which invade the periphery for about 1mm. But under pathologic conditions vessels invade the cornea from the limbal vascular plexus.
Niraimozhi, R
core
Effectiveness of Ultrathin 40-Gauge Needles for Intravitreal Injections. [PDF]
Cho YJ, Kook KY, Park DH, Ji YS.
europepmc +1 more source
XEN63 Gel Stent in Glaucoma: Narrative Review and Expert Perspectives on Patient Selection, Surgical Technique, and Perioperative Management. [PDF]
Ahmed IIK +8 more
europepmc +1 more source
Effects of Subconjunctival Bevacizumab and Ranibizumab on Corneal and Systemic Oxidative Stress Biomarkers in an Alkali Injury Model. [PDF]
Yarbağ A +3 more
europepmc +1 more source
Retinal changes and treatment in ocular alkali burn: a systematic review of animal models and case reports summary. [PDF]
Pothikamjorn TL +2 more
europepmc +1 more source
Systemic and ocular complications related to intravitreal administration of anti-VEGF agents. [PDF]
Koksaldi S +3 more
europepmc +1 more source

